Cutler Group LP Adma Biologics, Inc. Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$2.03 - $2.86 $4,059 - $5,720	2,000 New	2,000 $4,000
Q1 2022 Apr 14, 2022	SELL	$1.28 - $1.83 $37,788 - $54,025	-29,522 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$1.09 - $1.66 $436 - $664	400 Added 1.37%	29,522 $41,000
Q3 2021 Oct 26, 2021	SELL	$1.13 - $1.65 $20,180 - $29,467	-17,859 Reduced 38.01%	29,122 $32,000
Q2 2021 Jul 19, 2021	SELL	$1.51 - $2.07 $3,717 - $5,096	-2,462 Reduced 4.98%	46,981 $75,000
Q1 2021 Apr 26, 2021	BUY	$1.67 - $2.95 $78,812 - $139,219	47,193 Added 2097.47%	49,443 $87,000
Q4 2020 Jan 21, 2021	BUY	$1.8 - $2.56 $4,050 - $5,760	2,250 New	2,250 $4,000
Q4 2019 Feb 06, 2020	SELL	$3.89 - $5.15 $3,501 - $4,635	-900 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$2.61 - $4.35 $2,349 - $3,914	900 New	900 $3,000

314

187M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.22B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.